Invex Therapeutics (ASX:IXC) Dividends per Share: A$0.00 (TTM As of Dec. 2025)


What is Invex Therapeutics Dividends per Share?

Invex Therapeutics ASX:IXC Dividends per Share is A$0.00 as of Dec. 2025. The stock has 1 warning sign investors should review.

Invex Therapeutics's dividends per share for the six months ended in Dec. 2025 was A$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00. As of today, Invex Therapeutics's Dividend Yield % is 0.00%.

During the past 12 months, Invex Therapeutics's average Dividends Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Invex Therapeutics  (ASX:IXC) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Invex Therapeutics's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ -0.01
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invex Therapeutics Dividends per Share Related Terms

Invex Therapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Invex Therapeutics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invex Therapeutics Dividends per Share Chart

Invex Therapeutics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividends per Share
Get a 7-Day Free Trial 0.00 0.00 0.00 0.19 0.00

Invex Therapeutics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.00 0.00 0.00 0.00

ASX:IXC vs VRTX, REGN, ALNY: Dividends per Share Comparison

For the Biotechnology subindustry, Invex Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invex Therapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Invex Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Invex Therapeutics's Dividend Yield % falls into.


Invex Therapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of A$0.00 mean?
Invex Therapeutics (ASX:IXC) has a Dividends per Share of A$0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Invex Therapeutics and its competitors.
Is Invex Therapeutics' Dividends per Share too high?
Invex Therapeutics' current Dividends per Share is A$0.00.
How does Invex Therapeutics' Dividends per Share compare to VRTX and REGN?
Invex Therapeutics' Dividends per Share of A$0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Invex Therapeutics and its competitors. Invex Therapeutics's current Dividends per Share is A$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invex Therapeutics stock overvalued right now?
Invex Therapeutics (ASX:IXC) has a current Dividends per Share of A$0.00. The current Dividends per Share is A$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Invex Therapeutics (ASX:IXC), the current Dividends per Share is A$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Invex Therapeutics Business Description

Address c/- Automic Group, Level 5, 191 St Georges Terrace, Perth, WA, AUS, 6000
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.